Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort Study

Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort Study

Background The value of coronary artery calcium (CAC) in the allocation of PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitors) among individuals without clinically evident atherosclerotic cardiovascular disease (ASCVD) is unknown for indications that do not require confirmed familial h...

Full description

Bibliographic Details
Main Authors: Miguel Cainzos‐Achirica, Renato Quispe, Reed Mszar, Ramzi Dudum, Mahmoud Al Rifai, Raimund Erbel, Andreas Stang, Karl‐Heinz Jöckel, Nils Lehmann, Sara Schramm, Börge Schmidt, Peter P. Toth, Jamal S. Rana, Joao A. C. Lima, Henrique Doria de Vasconcellos, Donald Lloyd‐Jones, Parag H. Joshi, Colby Ayers, Amit Khera, Michael J. Blaha, Philip Greenland, Khurram Nasir
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atherosclerosis
cardiovascular disease
coronary artery calcium
PCSK9i
primary prevention
risk
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.025737

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.025737

Similar Items